Ionis Pharmaceuticals Inc. buy BMO Capital Markets
Start price
03.09.25
/
50%
€51.62
Target price
03.09.26
€60.18
Performance (%)
34.87%
Price
22.01.26
€69.62
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets for Ionis Pharmaceuticals Inc. has seen massive gains of 34.87%. This prediction currently runs until 03.09.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ionis Pharmaceuticals Inc. | 4.597% | 4.597% |
| iShares Core DAX® | -1.673% | 2.237% |
| iShares Nasdaq 100 | -1.346% | 0.290% |
| iShares Nikkei 225® | -1.529% | 5.863% |
| iShares S&P 500 | -1.702% | 0.697% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Ionis Pharmaceuticals (NASDAQ:IONS) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $70.00 price target on the stock.
Ratings data for IONS provided by MarketBeat